Curious about the stocks that are showing activity after the closing bell on Friday? Let's have a look at what is happening on the US markets after the closing bell on Friday. Below you can find the top gainers and losers in today's after hours session.
Ovid Therapeutics Stock Rallied 18% Pre-Market – Here’s Why The company is now looking forward to initiating a mid-stage study evaluating OV329 in adult patients with drug-resistant focal onset seizures.
These stocks that are showing activity before the opening bell on Friday. Wondering what's happening in Friday's pre-market session? Find an overview in this article.
Curious about the stocks that are showing activity after the closing bell on Tuesday? The US market regular session of Tuesday is over, let's have a look at the top gainers and losers in the after hours session today.
Top movers in Wednesday's session Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
Which stocks are moving after the closing bell on Tuesday? Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.
Get insights into the top gainers and losers of Friday's after-hours session. Discover the top movers in Friday's after-hours session and stay informed about the post-market dynamics.
Top movers in Wednesday's after hours session Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Top movers in Wednesday's pre-market session Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics.
OVID Stock Earnings: Ovid Therapeutics Beats EPS, Beats Revenue for Q2 2024 OVID stock results show that Ovid Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
7 Sorry Biotech Stocks Set to Make Investors Sad Biotech stocks can be extremely challenging because it takes a long time to bring a therapy to market. Here are some biotech stocks to sell.
